HomeCompareTRDFX vs JNJ

TRDFX vs JNJ: Dividend Comparison 2026

TRDFX yields 8.77% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRDFX wins by $15.7K in total portfolio value
10 years
TRDFX
TRDFX
● Live price
8.77%
Share price
$12.09
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.7K
Annual income
$1,525.09
Full TRDFX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TRDFX vs JNJ

📍 TRDFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRDFXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRDFX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRDFX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRDFX
Annual income on $10K today (after 15% tax)
$745.36/yr
After 10yr DRIP, annual income (after tax)
$1,296.33/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TRDFX beats the other by $592.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRDFX + JNJ for your $10,000?

TRDFX: 50%JNJ: 50%
100% JNJ50/50100% TRDFX
Portfolio after 10yr
$27.9K
Annual income
$1,176.44/yr
Blended yield
4.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TRDFX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRDFX buys
0
JNJ buys
0
No recent congressional trades found for TRDFX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRDFXJNJ
Forward yield8.77%3.36%
Annual dividend / share$1.06$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$35.7K$20.0K
Annual income after 10y$1,525.09$827.78
Total dividends collected$12.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TRDFX vs JNJ ($10,000, DRIP)

YearTRDFX PortfolioTRDFX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,577$876.89$10,676$355.77+$901.00TRDFX
2$13,336$948.75$11,407$389.39+$1.9KTRDFX
3$15,291$1,021.42$12,198$426.53+$3.1KTRDFX
4$17,456$1,094.53$13,056$467.62+$4.4KTRDFX
5$19,846$1,167.75$13,987$513.12+$5.9KTRDFX
6$22,475$1,240.76$14,998$563.56+$7.5KTRDFX
7$25,362$1,313.26$16,098$619.52+$9.3KTRDFX
8$28,522$1,384.98$17,295$681.69+$11.2KTRDFX
9$31,975$1,455.66$18,599$750.82+$13.4KTRDFX
10$35,738$1,525.09$20,022$827.78+$15.7KTRDFX

TRDFX vs JNJ: Complete Analysis 2026

TRDFXStock

Under normal circumstances, the fund will invest at least 80% of its assets in the securities of small- to mid-cap companies included in the fund’s benchmark index that pass the fund’s values-based screens. The companies included in the benchmark index represent a broad spectrum of the U.S. economy and are generally U.S. issuers. Its investments may also include other investment companies and real estate investment trusts.

Full TRDFX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TRDFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRDFX vs SCHDTRDFX vs JEPITRDFX vs OTRDFX vs KOTRDFX vs MAINTRDFX vs ABBVTRDFX vs MRKTRDFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.